Kenneth K. Tanabe
Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma.
Overview
Kenneth Tanabe is President of the Society of Surgical Oncology for 2026-2027 and Chief of Surgical Oncology at Massachusetts General Hospital, where he is a professor of surgery at Harvard Medical School. His clinical and research work focuses on hepatobiliary malignancies and melanoma, including hepatocellular carcinoma biology and oncolytic virus therapy. He has held numerous leadership roles in US surgical oncology.
Pages like this
not linked directly; found by shared links- PersonJia Fan
Shares Hepatocellular carcinoma and the tags leadership, clinician-scientist, surgical oncology, liver cancer.
- PersonTari A. King
Shares Society of Surgical Oncology and the tags leadership, clinician-scientist, surgical oncology.
- PersonLars Zender
Shares Hepatocellular carcinoma and the tags leadership, clinician-scientist, liver cancer.
- PersonJosep Maria Llovet
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonAntonio Rosato
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonBruno Sangro
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonSusana Puig
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonFrancisco Berrospi Espinoza
Shares Hepatocellular carcinoma and the tags leadership, clinician-scientist.